English

HUMAN PHEROMONE SCIENCES INC

EDGAR

Quarterly report (10-Q) · filed 2011-11-14

66 filing records in this dataset, filed from 1996-08-12 to 2011-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

113 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 113000 USD Source

Operating margin

-26.55%

2011-09-30 · %

Exact inputs and evidence

Operating Income: -30000 USD Source
Revenue: 113000 USD Source

Operating cash flow

-37 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -23000 USD Source
Operating Cash Flow: 14000 USD Source

Cash and cash equivalents: 69 thousand USD 2011-09-30 Source
Exact value

69000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

648 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 806000 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 581000 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 186000 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 124000 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 113000 USD · 2011-07-01 – 2011-09-30 Source

Net income

62 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: -97000 USD · 2010-01-01 – 2010-12-31 Source
Net income: -215000 USD · 2010-01-01 – 2010-09-30 Source
Net income: -7000 USD · 2011-01-01 – 2011-03-31 Source
Net income: -19000 USD · 2011-04-01 – 2011-06-30 Source
Net income: -30000 USD · 2011-07-01 – 2011-09-30 Source

Operating cash flow

34 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Operating cash flow: -258000 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: -315000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -37000 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: 14000 USD · 2011-01-01 – 2011-06-30 Source
Operating cash flow: -37000 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: -23000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: 14000 USD · 2011-01-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-11-14.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
Capital expenditure: 11 of 11 periods available· newest 2010-12-31
Total assets: 6 of 11 periods available· newest 2010-12-31
Total liabilities: 9 of 11 periods available· newest 2010-12-31
Current assets: 11 of 11 periods available· newest 2010-12-31
Current liabilities: 11 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-8.9%

Prior period

USD 885,000

2009-01-01 – 2009-12-31
Current period

USD 806,000

2010-01-01 – 2010-12-31

Exact inputs and evidence

806000 − 885000 = -79000 USD

885000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
806000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Year-over-year change in Revenue: -79000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 806000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#4751 Input fundies:Revenue: 885000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#4751
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 187,000

Prior period

−USD 284,000

2009-01-01 – 2009-12-31
Current period

−USD 97,000

2010-01-01 – 2010-12-31

Exact inputs and evidence

-97000 − -284000 = 187000 USD

-284000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-97000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Year-over-year change in Net income: 187000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -97000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5372 Input fundies:NetIncome: -284000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5372
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 299,000

Prior period

−USD 557,000

2009-01-01 – 2009-12-31
Current period

−USD 258,000

2010-01-01 – 2010-12-31

Exact inputs and evidence

-258000 − -557000 = 299000 USD

-557000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-258000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Year-over-year change in Operating cash flow: 299000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -258000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514 Input fundies:OperatingCashFlow: -557000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
USD 0

Prior period

USD 0

2009-01-01 – 2009-12-31
Current period

USD 0

2010-01-01 – 2010-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Year-over-year change in Capital expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 806,000 100% of revenue
Cost of revenue USD 128,000 16% of revenue
Operating expenses USD 773,000 96% of revenue
Operating income −USD 95,000 −12% of revenue
Tax, interest and other Derived USD 2,000 0.2% of revenue
Net income −USD 97,000 −12% of revenue

Cash

Operating cash flow −USD 258,000 −32% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 258,000 −32% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 101% of revenue.
2002 Operating loss: operating costs were 274% of revenue.
2003 Operating loss: operating costs were 196% of revenue.
2004 Operating loss: operating costs were 151% of revenue.
2005 Operating loss: operating costs were 330% of revenue.
2006 Operating loss: operating costs were 111% of revenue.
2007 Operating loss: operating costs were 106% of revenue.
2008 Operating loss: operating costs were 127% of revenue.
2009 Operating loss: operating costs were 132% of revenue.
2010 Operating loss: operating costs were 112% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	2500000	2517000 Derived	-17000	-26000 Derived	9000	377000 Derived	Source 2001-01-01 – 2001-12-31: 2500000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -17000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 9000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 378000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 1000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	554000	1519000 Derived	-965000	-752000 Derived	-213000	37000 Derived	Source 2002-01-01 – 2002-12-31: 554000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -965000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -213000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 40000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 3000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	646000	1264000 Derived	-618000	-1285000 Derived	667000	-404000 Derived	Source 2003-01-01 – 2003-12-31: 646000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -618000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 667000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -397000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 7000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1140000	1727000 Derived	-587000	-45000 Derived	-542000	-749000 Derived	Source 2004-01-01 – 2004-12-31: 1140000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -587000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -542000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -733000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 16000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	414000	1365000 Derived	-951000	-17000 Derived	-934000	-749000 Derived	Source 2005-01-01 – 2005-12-31: 414000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -951000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -934000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -748000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 1000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1227000	1358000 Derived	-131000	-20000 Derived	-111000	1489000 Derived	Source 2006-01-01 – 2006-12-31: 1227000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -131000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -111000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 1489000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	1291000	1367000 Derived	-76000	-60000 Derived	-16000	-504000 Derived	Source 2007-01-01 – 2007-12-31: 1291000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -76000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -16000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -501000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 3000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	992000	1258000 Derived	-266000	-27000 Derived	-239000	-530000 Derived	Source 2008-01-01 – 2008-12-31: 992000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -266000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -239000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -530000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	885000	1171000 Derived	-286000	-2000 Derived	-284000	-557000 Derived	Source 2009-01-01 – 2009-12-31: 885000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -286000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -284000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -557000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	806000	901000 Derived	-95000	2000 Derived	-97000	-258000 Derived	Source 2010-01-01 – 2010-12-31: 806000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -95000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -97000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -258000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 806K 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	2500000	Revenue: 2500000 Open source
20022002-12-31	Revenue	554000	Revenue: 554000 Open source
20032003-12-31	Revenue	646000	Revenue: 646000 Open source
20042004-12-31	Revenue	1140000	Revenue: 1140000 Open source
20052005-12-31	Revenue	414000	Revenue: 414000 Open source
20062006-12-31	Revenue	1227000	Revenue: 1227000 Open source
20072007-12-31	Revenue	1291000	Revenue: 1291000 Open source
20082008-12-31	Revenue	992000	Revenue: 992000 Open source
20092009-12-31	Revenue	885000	Revenue: 885000 Open source
20102010-12-31	Revenue	806000	Revenue: 806000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-8.9% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	-22.8%	Revenue: 2500000 Open source Revenue: 3239000 Open source
20022002-12-31	Year over year	-77.8%	Revenue: 554000 Open source Revenue: 2500000 Open source
20032003-12-31	Year over year	16.6%	Revenue: 646000 Open source Revenue: 554000 Open source
20042004-12-31	Year over year	76.5%	Revenue: 1140000 Open source Revenue: 646000 Open source
20052005-12-31	Year over year	-63.7%	Revenue: 414000 Open source Revenue: 1140000 Open source
20062006-12-31	Year over year	196.4%	Revenue: 1227000 Open source Revenue: 414000 Open source
20072007-12-31	Year over year	5.2%	Revenue: 1291000 Open source Revenue: 1227000 Open source
20082008-12-31	Year over year	-23.2%	Revenue: 992000 Open source Revenue: 1291000 Open source
20092009-12-31	Year over year	-10.8%	Revenue: 885000 Open source Revenue: 992000 Open source
20102010-12-31	Year over year	-8.9%	Revenue: 806000 Open source Revenue: 885000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -11.8% 2010

Net margin -12% 2010

Free cash flow margin -32% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	-0.7%	Operating Income: -17000 Open source Revenue: 2500000 Open source
20022002-12-31	Operating margin	-174.2%	Operating Income: -965000 Open source Revenue: 554000 Open source
20032003-12-31	Operating margin	-95.7%	Operating Income: -618000 Open source Revenue: 646000 Open source
20042004-12-31	Operating margin	-51.5%	Operating Income: -587000 Open source Revenue: 1140000 Open source
20052005-12-31	Operating margin	-229.7%	Operating Income: -951000 Open source Revenue: 414000 Open source
20062006-12-31	Operating margin	-10.7%	Operating Income: -131000 Open source Revenue: 1227000 Open source
20072007-12-31	Operating margin	-5.9%	Operating Income: -76000 Open source Revenue: 1291000 Open source
20082008-12-31	Operating margin	-26.8%	Operating Income: -266000 Open source Revenue: 992000 Open source
20092009-12-31	Operating margin	-32.3%	Operating Income: -286000 Open source Revenue: 885000 Open source
20102010-12-31	Operating margin	-11.8%	Operating Income: -95000 Open source Revenue: 806000 Open source
20012001-12-31	Net margin	0.4%	Net Income: 9000 Open source Revenue: 2500000 Open source
20022002-12-31	Net margin	-38.4%	Net Income: -213000 Open source Revenue: 554000 Open source
20032003-12-31	Net margin	103.3%	Net Income: 667000 Open source Revenue: 646000 Open source
20042004-12-31	Net margin	-47.5%	Net Income: -542000 Open source Revenue: 1140000 Open source
20052005-12-31	Net margin	-225.6%	Net Income: -934000 Open source Revenue: 414000 Open source
20062006-12-31	Net margin	-9%	Net Income: -111000 Open source Revenue: 1227000 Open source
20072007-12-31	Net margin	-1.2%	Net Income: -16000 Open source Revenue: 1291000 Open source
20082008-12-31	Net margin	-24.1%	Net Income: -239000 Open source Revenue: 992000 Open source
20092009-12-31	Net margin	-32.1%	Net Income: -284000 Open source Revenue: 885000 Open source
20102010-12-31	Net margin	-12%	Net Income: -97000 Open source Revenue: 806000 Open source
20012001-12-31	Free cash flow margin	15.1%	Revenue: 2500000 Open source Operating Cash Flow: 378000 Open source Capital Expenditure: 1000 Open source
20022002-12-31	Free cash flow margin	6.7%	Revenue: 554000 Open source Operating Cash Flow: 40000 Open source Capital Expenditure: 3000 Open source
20032003-12-31	Free cash flow margin	-62.5%	Revenue: 646000 Open source Operating Cash Flow: -397000 Open source Capital Expenditure: 7000 Open source
20042004-12-31	Free cash flow margin	-65.7%	Revenue: 1140000 Open source Operating Cash Flow: -733000 Open source Capital Expenditure: 16000 Open source
20052005-12-31	Free cash flow margin	-180.9%	Revenue: 414000 Open source Operating Cash Flow: -748000 Open source Capital Expenditure: 1000 Open source
20062006-12-31	Free cash flow margin	121.4%	Revenue: 1227000 Open source Operating Cash Flow: 1489000 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow margin	-39%	Revenue: 1291000 Open source Operating Cash Flow: -501000 Open source Capital Expenditure: 3000 Open source
20082008-12-31	Free cash flow margin	-53.4%	Revenue: 992000 Open source Operating Cash Flow: -530000 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow margin	-62.9%	Revenue: 885000 Open source Operating Cash Flow: -557000 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow margin	-32%	Revenue: 806000 Open source Operating Cash Flow: -258000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -258K 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	378000	Operating Cash Flow: 378000 Open source
20022002-12-31	Operating cash flow	40000	Operating Cash Flow: 40000 Open source
20032003-12-31	Operating cash flow	-397000	Operating Cash Flow: -397000 Open source
20042004-12-31	Operating cash flow	-733000	Operating Cash Flow: -733000 Open source
20052005-12-31	Operating cash flow	-748000	Operating Cash Flow: -748000 Open source
20062006-12-31	Operating cash flow	1489000	Operating Cash Flow: 1489000 Open source
20072007-12-31	Operating cash flow	-501000	Operating Cash Flow: -501000 Open source
20082008-12-31	Operating cash flow	-530000	Operating Cash Flow: -530000 Open source
20092009-12-31	Operating cash flow	-557000	Operating Cash Flow: -557000 Open source
20102010-12-31	Operating cash flow	-258000	Operating Cash Flow: -258000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -258K 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	377000	Operating Cash Flow: 378000 Open source Capital Expenditure: 1000 Open source
20022002-12-31	Free cash flow	37000	Operating Cash Flow: 40000 Open source Capital Expenditure: 3000 Open source
20032003-12-31	Free cash flow	-404000	Operating Cash Flow: -397000 Open source Capital Expenditure: 7000 Open source
20042004-12-31	Free cash flow	-749000	Operating Cash Flow: -733000 Open source Capital Expenditure: 16000 Open source
20052005-12-31	Free cash flow	-749000	Operating Cash Flow: -748000 Open source Capital Expenditure: 1000 Open source
20062006-12-31	Free cash flow	1489000	Operating Cash Flow: 1489000 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow	-504000	Operating Cash Flow: -501000 Open source Capital Expenditure: 3000 Open source
20082008-12-31	Free cash flow	-530000	Operating Cash Flow: -530000 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow	-557000	Operating Cash Flow: -557000 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow	-258000	Operating Cash Flow: -258000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

114.2% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	No source recorded
20022002-12-31	Liabilities / assets	Not reported	Total Liabilities: 4002000 Open source
20032003-12-31	Liabilities / assets	Not reported	Total Liabilities: 323000 Open source
20042004-12-31	Liabilities / assets	Not reported	Total Liabilities: 195000 Open source
20052005-12-31	Liabilities / assets	25%	Total Liabilities: 140000 Open source Total Assets: 559000 Open source
20062006-12-31	Liabilities / assets	82.5%	Total Liabilities: 1711000 Open source Total Assets: 2075000 Open source
20072007-12-31	Liabilities / assets	73.7%	Total Liabilities: 1253000 Open source Total Assets: 1699000 Open source
20082008-12-31	Liabilities / assets	72.9%	Total Liabilities: 771000 Open source Total Assets: 1058000 Open source
20092009-12-31	Liabilities / assets	92.7%	Total Liabilities: 547000 Open source Total Assets: 590000 Open source
20102010-12-31	Liabilities / assets	114.2%	Total Liabilities: 314000 Open source Total Assets: 275000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.95× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	3.73×	Current Assets: 2567000 Open source Current Liabilities: 688000 Open source
20022002-12-31	Current assets / current liabilities	6.65×	Current Assets: 1967000 Open source Current Liabilities: 296000 Open source
20032003-12-31	Current assets / current liabilities	11.9×	Current Assets: 2059000 Open source Current Liabilities: 173000 Open source
20042004-12-31	Current assets / current liabilities	7.85×	Current Assets: 1531000 Open source Current Liabilities: 195000 Open source
20052005-12-31	Current assets / current liabilities	3.94×	Current Assets: 551000 Open source Current Liabilities: 140000 Open source
20062006-12-31	Current assets / current liabilities	2.09×	Current Assets: 2073000 Open source Current Liabilities: 990000 Open source
20072007-12-31	Current assets / current liabilities	2.47×	Current Assets: 1696000 Open source Current Liabilities: 687000 Open source
20082008-12-31	Current assets / current liabilities	2.36×	Current Assets: 1056000 Open source Current Liabilities: 447000 Open source
20092009-12-31	Current assets / current liabilities	1.51×	Current Assets: 589000 Open source Current Liabilities: 389000 Open source
20102010-12-31	Current assets / current liabilities	0.95×	Current Assets: 275000 Open source Current Liabilities: 290000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	USD 9,000 Exact value Exact value: 9000 USD 2001-01-01 – 2001-12-31: 9000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2001-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: 9000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-03-000374.txt#1670 The citation records this snapshot. The page link may show a newer release later.	USD 378,000 Exact value Exact value: 378000 USD 2001-01-01 – 2001-12-31: 378000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2001-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: 378000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 378000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-03-000374.txt#1681 The citation records this snapshot. The page link may show a newer release later.	USD 1,000 Exact value Exact value: 1000 USD 2001-01-01 – 2001-12-31: 1000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2001-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-03-000374.txt#1686 The citation records this snapshot. The page link may show a newer release later.	USD 377,000 Calculation and evidence 378000 − 1000 USD Exact free cash flow: 377000 USD 2001-01-01 – 2001-12-31: 378000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2001-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: 377000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 378000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-03-000374.txt#1681 Input fundies:CapitalExpenditure: 1000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-03-000374.txt#1686 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 213,000 Exact value Exact value: -213000 USD 2002-01-01 – 2002-12-31: -213000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2002-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -213000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -213000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-04-000321.txt#1475 The citation records this snapshot. The page link may show a newer release later.	USD 40,000 Exact value Exact value: 40000 USD 2002-01-01 – 2002-12-31: 40000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2002-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: 40000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 40000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-04-000321.txt#1572 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2002-01-01 – 2002-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2002-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-04-000321.txt#1576 The citation records this snapshot. The page link may show a newer release later.	USD 37,000 Calculation and evidence 40000 − 3000 USD Exact free cash flow: 37000 USD 2002-01-01 – 2002-12-31: 40000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2002-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: 37000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 40000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-04-000321.txt#1572 Input fundies:CapitalExpenditure: 3000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-04-000321.txt#1576 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 667,000 Exact value Exact value: 667000 USD 2003-01-01 – 2003-12-31: 667000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2003-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: 667000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 667000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-05-000301.txt#1386 The citation records this snapshot. The page link may show a newer release later.	−USD 397,000 Exact value Exact value: -397000 USD 2003-01-01 – 2003-12-31: -397000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2003-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -397000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -397000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-05-000301.txt#1484 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2003-01-01 – 2003-12-31: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2003-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-05-000301.txt#1488 The citation records this snapshot. The page link may show a newer release later.	−USD 404,000 Calculation and evidence -397000 − 7000 USD Exact free cash flow: -404000 USD 2003-01-01 – 2003-12-31: -397000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2003-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -404000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -397000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-05-000301.txt#1484 Input fundies:CapitalExpenditure: 7000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-05-000301.txt#1488 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 542,000 Exact value Exact value: -542000 USD 2004-01-01 – 2004-12-31: -542000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2004-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -542000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -542000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-06-000234.txt#1298 The citation records this snapshot. The page link may show a newer release later.	−USD 733,000 Exact value Exact value: -733000 USD 2004-01-01 – 2004-12-31: -733000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2004-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -733000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -733000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-06-000234.txt#1370 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2004-01-01 – 2004-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2004-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-06-000234.txt#1373 The citation records this snapshot. The page link may show a newer release later.	−USD 749,000 Calculation and evidence -733000 − 16000 USD Exact free cash flow: -749000 USD 2004-01-01 – 2004-12-31: -733000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2004-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -749000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -733000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-06-000234.txt#1370 Input fundies:CapitalExpenditure: 16000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-06-000234.txt#1373 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 934,000 Exact value Exact value: -934000 USD 2005-01-01 – 2005-12-31: -934000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2005-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -934000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -934000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-07-000178.txt#1065 The citation records this snapshot. The page link may show a newer release later.	−USD 748,000 Exact value Exact value: -748000 USD 2005-01-01 – 2005-12-31: -748000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2005-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -748000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -748000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-07-000178.txt#1106 The citation records this snapshot. The page link may show a newer release later.	USD 1,000 Exact value Exact value: 1000 USD 2005-01-01 – 2005-12-31: 1000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2005-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-07-000178.txt#1113 The citation records this snapshot. The page link may show a newer release later.	−USD 749,000 Calculation and evidence -748000 − 1000 USD Exact free cash flow: -749000 USD 2005-01-01 – 2005-12-31: -748000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 1000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2005-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -749000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -748000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-07-000178.txt#1106 Input fundies:CapitalExpenditure: 1000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-07-000178.txt#1113 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 111,000 Exact value Exact value: -111000 USD 2006-01-01 – 2006-12-31: -111000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2006-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -111000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -111000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-08-000200.txt#1307 The citation records this snapshot. The page link may show a newer release later.	USD 1.49 million Exact value Exact value: 1489000 USD 2006-01-01 – 2006-12-31: 1489000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2006-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: 1489000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1489000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-08-000200.txt#1348 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2006-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-08-000200.txt#1355 The citation records this snapshot. The page link may show a newer release later.	USD 1.49 million Calculation and evidence 1489000 − 0 USD Exact free cash flow: 1489000 USD 2006-01-01 – 2006-12-31: 1489000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2006-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: 1489000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1489000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-08-000200.txt#1348 Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-08-000200.txt#1355 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 16,000 Exact value Exact value: -16000 USD 2007-01-01 – 2007-12-31: -16000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2007-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -16000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-09-000162.txt#1447 The citation records this snapshot. The page link may show a newer release later.	−USD 501,000 Exact value Exact value: -501000 USD 2007-01-01 – 2007-12-31: -501000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2007-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -501000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -501000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-09-000162.txt#1488 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2007-01-01 – 2007-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2007-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-09-000162.txt#1495 The citation records this snapshot. The page link may show a newer release later.	−USD 504,000 Calculation and evidence -501000 − 3000 USD Exact free cash flow: -504000 USD 2007-01-01 – 2007-12-31: -501000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2007-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -504000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -501000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-09-000162.txt#1488 Input fundies:CapitalExpenditure: 3000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-09-000162.txt#1495 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 239,000 Exact value Exact value: -239000 USD 2008-01-01 – 2008-12-31: -239000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2008-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -239000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -239000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-10-000147.txt#2180 The citation records this snapshot. The page link may show a newer release later.	−USD 530,000 Exact value Exact value: -530000 USD 2008-01-01 – 2008-12-31: -530000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2008-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -530000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -530000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-10-000147.txt#2221 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2008-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-10-000147.txt#2228 The citation records this snapshot. The page link may show a newer release later.	−USD 530,000 Calculation and evidence -530000 − 0 USD Exact free cash flow: -530000 USD 2008-01-01 – 2008-12-31: -530000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2008-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -530000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -530000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-10-000147.txt#2221 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0000950005-10-000147.txt#2228 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 284,000 Exact value Exact value: -284000 USD 2009-01-01 – 2009-12-31: -284000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2009-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -284000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -284000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5372 The citation records this snapshot. The page link may show a newer release later.	−USD 557,000 Exact value Exact value: -557000 USD 2009-01-01 – 2009-12-31: -557000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2009-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -557000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -557000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2009-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548 The citation records this snapshot. The page link may show a newer release later.	−USD 557,000 Calculation and evidence -557000 − 0 USD Exact free cash flow: -557000 USD 2009-01-01 – 2009-12-31: -557000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2009-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -557000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -557000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 97,000 Exact value Exact value: -97000 USD 2010-01-01 – 2010-12-31: -97000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Net Income: -97000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5372 The citation records this snapshot. The page link may show a newer release later.	−USD 258,000 Exact value Exact value: -258000 USD 2010-01-01 – 2010-12-31: -258000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Operating Cash Flow: -258000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -258000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548 The citation records this snapshot. The page link may show a newer release later.	−USD 258,000 Calculation and evidence -258000 − 0 USD Exact free cash flow: -258000 USD 2010-01-01 – 2010-12-31: -258000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HUMAN PHEROMONE SCIENCES INC · 2010-12-31 HUMAN PHEROMONE SCIENCES INC (edgar:878616) Free cash flow: -258000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/878616?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -258000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5514 Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/878616/0001144204-11-018278.txt#5548 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000878616, 878616, edgar:878616

Also known as EROX CORP

HUMAN PHEROMONE SCIENCES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation